Human Genome Sciences Closed Tuesday At Second Consecutive New High For Year
Do you know when to trade HGSI ?
Human Genome Sciences and GlaxoSmithKline PLC (GSK | Quote | Chart | News | PowerRating) announced Monday morning that BENLYSTA met the primary endpoint in the second of two Phase 3 trials in seropositive patients with systemic lupus erythematosus. Human Genome Sciences closed Tuesday at its second consecutive new high for the year.
For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
For full details on Human Genome Sciences (HGSI) HGSI. Human Genome Sciences (HGSI) has Short Term PowerRatings at TradingMarkets. Details on Human Genome Sciences (HGSI) Short Term PowerRatings is available at This Link.
- www.StockMarketingInc.com: Welcome To Stock Marketing Inc!! Sign Up Today!! CYTK,CVGI,CRTP,HSGI,AMCC,OXGN - 03/19/10
- Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at the Barclays Capital Healthcare Conference - 03/19/10
- BiomedReports: News and FDA Updates for CytoDyn (OTC:CYDY), Human Genome (Nasdaq:HGSI), Idera (Nasdaq:IDRA) - 03/18/10
- Human Genome Sciences Announces Results of Randomized Phase 2 Trial of Mapatumumab in Non-Small Cell Lung Cancer - 03/17/10
- Human Genome Sciences Utilizes Aegis' Discoverant for Manufacturing Data Management, Analysis and Reporting - 03/16/10
- More News >>


